Drug recall · February 1, 2023
Vancomycin Hydrochloride for Injection recall
Why: Presence of Particulate Matter: Glass particulate matter detected in injectable.
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
Vancomycin Hydrochloride for Injection, USP, 1.5 g/vial, Sterile powder, Single-dose Fliptop Vial, 10 vials per carton, Rx only, Distributed by: Hospira, Inc., Lake Forest, IL 60045. NDC Vial 0409-3515-11; NDC Carton 0409-3515-01
- Lots / codes
Lot: 33045BA, EXP 1SEP2023
- Quantity
- 89,700 vials
- Company
- Pfizer Inc., New York, NY
- Distribution
- USA nationwide and Puerto Rico
- Initiated
- December 22, 2022 · Voluntary: Firm initiated
- Classified
- January 25, 2023
- Reported
- February 1, 2023
- Ended
- August 7, 2024
- How notified
- Press Release
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Vancomycin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.